JUSTIN GRANNELL: Open Payments
NPI 1609197391 · BRISTOL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,108 in 127 payments from 27 companies in 2025. Trend: 2023 $3,099 · 2024 $3,092 · 2025 $3,108
Food & beverage: $3,089Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $360 |
| PFIZER INC. | 16 | $314 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $283 |
| Amgen Inc. | 7 | $279 |
| Lilly USA, LLC | 9 | $256 |
| GlaxoSmithKline, LLC. | 15 | $214 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $211 |
| ABBVIE INC. | 10 | $191 |
| Novo Nordisk Inc | 4 | $174 |
| Vanda Pharmaceuticals Inc. | 3 | $101 |
Products named: JARDIANCE, Kerendia, TRELEGY ELLIPTA, AIRSUPRA, VRAYLAR, OTEZLA, Ozempic, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
